Cited by 5,228Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health EffectsLiver physiology and pathology

The DOI matches its Crossref record; 90 of the 92 references it cites were found in a registry or an index, and 2 are not checked yet.

Nonalcoholic Fatty Liver Disease

Angulo, Paul·2002·New England Journal of Medicine

DOI 10.1056/nejmra011775

Open this paper in CoChat — free account

Abstract

Alcohol abuse is the most common cause of fatty liver disease, but it is now apparent that fat deposition in the liver, and its consequences, may occur without alcohol abuse. The principal risk factors are obesity, non-insulin-dependent diabetes mellitus, and hyperlipidemia. The disorder has a wide clinical spectrum, ranging from asymptomatic steatosis to steatohepatitis, fibrosis, and cirrhosis. This article provides a broad overview of this increasingly recognized liver disease.

Integrity signals

Registry

Crossref · 10.1056/nejmra011775

Cites

90 of 92 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K., & Lindor, K. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,708
Self-citation
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Nonalcoholic Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Liver Fibrosis in the Severely Obese
Dixon, J. B., Bhathal, P. S., & O’Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,369
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,267
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
Caldwell, S. H., Oelsner, D. H., Iezzoni, J. C., Hespenheide, E. E., Battle, E. H., & Driscoll, C. J. (1999) · Hepatology · doi:10.1002/hep.510290347 · Cited by 1,138
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137
Steatosis Accelerates the Progression of Liver Damage of Chronic Hepatitis C Patients and Correlates With Specific Hcv Genotype and Visceral Obesity
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,052
Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., & Leonard, E. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9233 · Cited by 984
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, É., Thibault, V., Theodorou, I. D., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 969
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 913
The metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893
Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study
Becker, U., Deis, A., Sørensen, T. I. A., Grønbæk, M., Borch‐Johnsen, K., Muller, C. F., Schnohr, P., & Jensen, G. B. (1996) · Hepatology · doi:10.1002/hep.510230513 · Cited by 847
Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M. G., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 818
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
Leclercq, I. A., Farrell, G. C., Field, J., Bell, D., Gonzalez, F. J., & Robertson, G. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8814 · Cited by 763
Modulation of Insulin Activities by Leptin
Cohen, B., Novick, D., & Rubinstein, M. (1996) · Science · doi:10.1126/science.274.5290.1185 · Cited by 716
Metformin in non-alcoholic steatohepatitis.
Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682
Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis
George, D. K., Goldwurm, S., Macdonald, G. A., Cowley, L. L., Walker, N. I., Ward, P. J., Jazwinska, E. C., & Powell, L. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70482-2 · Cited by 653
Drinking habits as cofactors of risk for alcohol induced liver damage
Bellentani, S., Saccoccio, G., Costa, G., Tiribelli, C., Manenti, F., Sodde, M., Croce’, L. S., Sasso, F., Pozzato, G., Cristianini, G., et al. (1997) · Gut · doi:10.1136/gut.41.6.845 · Cited by 630
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
Weltman, M., Farrell, G. C., Hall, P. D. L. Μ., Ingelman‐Sundberg, M., & Liddle, C. (1998) · Hepatology · doi:10.1002/hep.510270121 · Cited by 613
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
Ueno, T., Sugawara, H., Sujaku, K., Hashimoto, O., Tsuji, R., Tamaki, S., Torimura, T., Inuzuka, S., Sata, M., & Tanikawa, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80287-5 · Cited by 608
Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study
Laurin, J. M., Lindor, K., Crippin, J. S., Gossard, A. A., Gores, G. J., Ludwig, J., Rakela, J. L., & McGill, D. B. (1996) · Hepatology · doi:10.1002/hep.510230624 · Cited by 565
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
Lavine, J. E. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)05040-x · Cited by 564
Nonalcoholic steatohepatitis: A study of 49 patients
Lee, R. G. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90249-9 · Cited by 547
Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease
Joseph, A. E. A., Saverymuttu, S. H., Al‐Sam, S., Cook, M. G., & Maxwell, J. D. (1991) · Clinical Radiology · doi:10.1016/s0009-9260(05)80350-2 · Cited by 514
Mitochondrial abnormalities in non-alcoholic steatohepatitis
Caldwell, S. H., Swerdlow, R. H., Khan, E. M., Iezzoni, J. C., Hespenheide, E. E., Parks, J. K., & Parker, W. D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80033-6 · Cited by 495
Insulin resistance–associated hepatic iron overload
Mendler, M.-H., Turlin, B., Moirand, R., Jouanolle, A., Sapey, T., Guyader, D., Gall, J. L., Brissot, P., David, V., & Deugnier, Y. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70401-4 · Cited by 494
Alterations in Liver ATP Homeostasis in Human Nonalcoholic Steatohepatitis
Cortez‐Pinto, H., Chatham, J. C., Chacko, V. P., Arnold, C., Rashid, A., & Diehl, A. M. (1999) · JAMA · doi:10.1001/jama.282.17.1659 · Cited by 487
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A. J., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 487
Alcohollike liver disease in nonalcoholics
Diehl, A. M., Goodman, Z. D., & Ishak, K. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90183-7 · Cited by 484
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diabetes.46.1.3 · Cited by 479
Obesity Induces Expression of Uncoupling Protein-2 in Hepatocytes and Promotes Liver ATP Depletion
Chavin, K. D., Yang, S., Lin, H. Z., Chatham, J. C., Chacko, V. P., Hoek, J. B., Walajtys-Rode, E., Rashid, A., Chen, C., Huang, C., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5692 · Cited by 443
Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study
Abdelmalek, M. F., Angulo, P., Jorgensen, R. A., Sylvestre, P. B., & Lindor, K. D. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04129.x · Cited by 439
Self-citation
Nonalcoholic Steatohepatitis in Children
Rashid, M., & Roberts, E. A. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200001000-00017 · Cited by 413
Plasma transforming growth factor‐β1 level and efficacy of α‐tocopherol in patients with non‐alcoholic steatohepatitis: a pilot study
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 407
Hepatic effects of dietary weight loss in morbidly obese subjects
Andersen, T., Gluud, C. N., Franzmann, M., & Christoffersen, P. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90942-5 · Cited by 405
Prevalence of fatty liver in Japanese children and relationship to obesity
Tominaga, K., Kurata, J. H., Chen, Y. K., Fujimoto, E. K., Miyagawa, S., Abe, I., & Kusano, Y. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02208670 · Cited by 405
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
Contos, M. J., Cales, W., Sterling, R. K., Luketic, V. A., Shiffman, M. L., Mills, A. S., Fisher, R. A., Ham, J. M., & Sanyal, A. J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23011 · Cited by 400
Fatty liver hepatitis and cirrhosis in obese patients
Adler, M., & Schaffner, F. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90740-x · Cited by 399
A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.
Caldwell, S. H., Hespenheide, E. E., Redick, J. A., Iezzoni, J. C., Battle, E. H., & Sheppard, B. L. (2001) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03553.x · Cited by 394
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis
Longo, R., Pollesello, P., Ricci, C., Masutti, F., Kvam, B. J., Bercich, L., Crocè, L. S., Grigolato, P., Paoletti, S., de BERNARD, B., et al. (1995) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880050311 · Cited by 388
Effect of weight reduction on hepatic abnormalities in overweight patients
Palmer, M., & Schaffner, F. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91169-7 · Cited by 369
Liver Involvement in Obese Children (Ultrasonography and Liver Enzyme Levels at Diagnosis and During Follow-up in an Italian Population)
Saviano, M. C., Brunetti, F., Rubino, A., Franzese, A., Vajro, P., Argenziano, A., Puzziello, A., & Iannucci, M. P. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018850223495 · Cited by 365
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis
Bonkovsky, H. L., Jawaid, Q., Tortorelli, K., LeClair, P., Cobb, J., Lambrecht, R. W., & Banner, B. F. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80032-4 · Cited by 361
Fatty Infiltration of Liver in Hyperlipidemic Patients
Assy, N., Kaita, K., Mymin, D., Levy, C., Rosser, B. G., & Minuk, G. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005661516165 · Cited by 360
Prevalence of fatty liver in a general population of Okinawa, Japan.
Nomura, H., Kashiwagi, S., Hayashi, J., Kajiyama, W., Tani, S., & Goto, M. (1988) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.27.142 · Cited by 353
Prospective Evaluation of Unexplained Chronic Liver Transaminase Abnormalities in Asymptomatic and Symptomatic Patients
Daniel, S., Ben‐Menachem, T., Vasudevan, G., Chan, K. M., & Blumenkehl, M. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01451.x · Cited by 353
Steatohepatitis, Spontaneous Peroxisome Proliferation and Liver Tumors in Mice Lacking Peroxisomal Fatty Acyl-CoA Oxidase
Fan, C.-Y., Pan, J., Usuda, N., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15639 · Cited by 343
Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus
Maddux, B. A., Sbraccia, P., Kumakura, S., Sasson, S., YOUNGREN, J. F., Fisher, A., Spencer, S. A., Grupe, A., Henzel, W. J., Stewart, T. A., et al. (1995) · Nature · doi:10.1038/373448a0 · Cited by 308
A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis
Başaranoğlu, M., Açbay, Ö., & Sonsuz, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80243-8 · Cited by 304
Liver pathology in morbidly obese patients with and without diabetes.
Silverman, J. F., O’Brien, K. F., Long, S., Leggett-Frazier, N., Khazanie, P. G., Pories, W. J., Norris, H. T., & F., J. (1990) · PubMed · Cited by 301
Rad: a Member of the Ras Family Overexpressed in Muscle of Type II Diabetic Humans
Reynet, C., & Kahn, C. R. (1993) · Science · doi:10.1126/science.8248782 · Cited by 300
Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds
Struben, V. M. D., Hespenheide, E. E., & Caldwell, S. H. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00315-0 · Cited by 295
Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass
Drenick, E. J., Simmons, F., & Murphy, J. F. (1970) · New England Journal of Medicine · doi:10.1056/nejm197004092821502 · Cited by 287
Idiopathic steatohepatitis in childhood: A multicenter retrospective study
Baldridge, A. D., Pérez‐Atayde, A. R., Graeme‐Cook, F., Higgins, L., & Lavine, J. E. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70156-7 · Cited by 281
The lipid peroxidation end product 4‐hydroxy‐2,3‐nonenal up‐regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis 1
Leonarduzzi, G., Scavazza, A., Biasi, F., Chiarpotto, E., Camandola, S., Vogl, S., Dargel, R., & Poli, G. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.11.9285483 · Cited by 264
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease
Charlton, M., Kasparova, P., Weston, S., Lindor, K., Maor-Kendler, Y., Wiesner, R. H., Rosen, C. B., & Batts, K. P. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25453 · Cited by 258
Hepatic iron and nonalcoholic fatty liver disease
Younossi, Z. M., Gramlich, T., Bacon, B. R., Matteoni, C. A., Boparai, N., O’Neill, R., & McCullough, A. J. (1999) · Hepatology · doi:10.1002/hep.510300407 · Cited by 236
Nonalcoholic steatohepatitis
Cortez‐Pinto, H., Baptista, A., Camilo, M., Valente, A. I., Saragoça, A., & de Moura, M. C. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02208601 · Cited by 220
Is Liver Biopsy Useful in the Evaluation of Patients with Chronically Elevated Liver Enzymes?
Ness, M. M. V., & Diehl, A. M. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-6-473 · Cited by 209
Nonalcoholic Steatohepatitis in Obesity: A Reversible Condition
Eriksson, S., Eriksson, K., & BONDESSON, L. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb02733.x · Cited by 197
Fatty liveran additional and treatable feature of the insulin resistance syndrome
Knobler, H. (1999) · QJM · doi:10.1093/qjmed/92.2.73 · Cited by 196
Persistent hyperaminotransferasemia resolving after weight reduction in obese children
Vajro, P., Fontanella, A., Perna, C., Orso, G., Tedesco, M., & Vincenzo, A. D. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70202-0 · Cited by 193
Reactive Oxygen Intermediates Are Involved in the Induction of CD95 Ligand mRNA Expression by Cytostatic Drugs in Hepatoma Cells
Hug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28191 · Cited by 177
Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.
Itoh, S., Yougel, T., & Kawagoe, K. (1987) · PubMed · Cited by 174
Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor
Lancaster, J. R., Laster, S. M., & Gooding, L. R. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80454-5 · Cited by 146
Liver morphology and function tests in obesity and during total starvation
Rozental, P., Biava, C. G., Spencer, H., & Zimmerman, H. J. (1967) · Digestive Diseases and Sciences · doi:10.1007/bf02233443 · Cited by 142
Non‐alcoholic steatohepatitis in children and adolescents
Manton, N. D., Lipsett, J., Moore, D., Davidson, G. P., Bourne, A. J., & Couper, R. T. L. (2000) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb139299.x · Cited by 139
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
Lavine, J. E. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.106566 · Cited by 139
Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+/H+exchanger isoform NHE3
Akhter, S., Nath, S., Tse, C., Williams, J. I., ZASLOFF, M. A., & Donowitz, M. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.1.c136 · Cited by 137
Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function.
Higuchi, M., Aggarwal, B. B., & Yeh, E. T. H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119339 · Cited by 135
Focal manifestations of diffuse liver disease at MR imaging.
Mitchell, D. G. (1992) · Radiology · doi:10.1148/radiology.185.1.1523289 · Cited by 119
Processing/activation of CPP32-like proteases is involved in transforming growth factor β1-induced apoptosis in rat hepatocytes
Inayat‐Hussain, S. H., Couet, C., Cohen, G. M., & Cain, K. (1997) · Hepatology · doi:10.1002/hep.510250634 · Cited by 88
Effect of Leptin on Cytochrome P-450, Conjugation, and Antioxidant Enzymes in the ob/ob Mouse
Watson, A. M., Poloyac, S. M., Howard, G., & Blouin, R. A. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15307-x · Cited by 80
Chemotactic activity of hydroxyalkenals on rat neutrophils.
Curzio, M., Esterbauer, H., & Mu, D. (1985) · PubMed · Cited by 61
Factors determining cirrhosis in alcoholic liver disease
BIRD, G., & Williams, R. L. (1988) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(88)90017-9 · Cited by 56
High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter.
Zatloukal, K., Böck, G., Rainer, I., Denk, H., & Weber, K. (1991) · PubMed · Cited by 41
Frequency of abnormalities detected by abdominal ultrasound among Japanese adults
OSHIBUCHI, M., Nishi, F., Sato, M., Ohtake, H., & Okuda, K. (1991) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1991.tb01459.x · Cited by 36
Glutathione depletion by hyperphagia-induced obesity
Sastre, J., Pallardó, F. V., Llopis, J., Furukawa, T., Vinã, J. R., & Viña, J. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90293-2 · Cited by 35
Glutamine prevents TNFα-induced bacterial translocation by acting as a specific metabolic fuel
Clark, E. C., Patel, S. D., Chadwick, P. R., & Carlson, G. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)81627-7 · Cited by 2

Flagged first, then by citations

Research works printed but not linked: 9

Schaffner F, 1986, Prog Liver Dis, 8, 283
Itoh S, 1987, Am J Gastroenterol, 82, 650
Silverman JF, 1990, Am J Gastroenterol, 85, 1349
Creutzfeldt W, 1970, Prog Liver Dis, 3, 371
Silverman JF, 1989, Pathol Annu, 24, 275
Debaere C, 1998, J Belge Radiol, 81, 174
Zatloukal K, 1991, Lab Invest, 64, 200
Curzio M, 1985, Int J Tissue React, 7, 137
Watson AM, 1999, Drug Metab Dispos, 27, 695

Sorted by citations

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Obesity in children and young people: a crisis in public health
Lobstein, T., Baur, L., & Uauy, R. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00133.x · Cited by 3,801
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,146
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119

See all 5,228

Authors: Angulo, P.
Affiliations: Mayo Clinic (US)
Corresponding author: Angulo, Paul
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2002-04-18
Volume: 346
Issue: 16
Pages: 1221-1231
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra011775
OpenAlex: W2040109162
Cited by: 5,228
References: 90
Citations by year: 2026: 38 · 2025: 80 · 2024: 102 · 2023: 171 · 2022: 155 · 2021: 191 · 2020: 246 · 2019: 228 · 2018: 222 · 2017: 264 · 2016: 275 · 2015: 339 · 2014: 368 · 2013: 319 · 2012: 309
FWCI: 23.15
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: non-alcoholic fatty liver disease, hepatic steatosis, steatohepatitis, liver fibrosis, liver cirrhosis, obesity, type 2 diabetes, hyperlipidemia, risk factors, alcohol abuse
MeSH terms: Biopsy, Fatty Liver, Humans, Liver, Liver Function Tests, Radiography, Risk Factors, Ultrasonography, Weight Loss, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonalcoholic Fatty Liver Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks